Evaluation of immunotherapeutic potential of Ocimum sanctumin bovine subclinical mastitis

Evaluation of immunotherapeutic potential of Ocimum sanctumin bovine subclinical mastitis

Mastitis, the inflammation of mammary glands, is caused by a wide range of contagious and environmental microbes, whose clearance from the udder is generally dependent on the use of antibiotics. However, antibiotic therapy may result in development of drug-resistant microbes and depress the activity of polymorphonuclear cells. The present study was therefore undertaken to explore the immunotherapeutic potential of an herb, Ocimum sanctum,in mastitis in dairy cows. The study involved twenty HF × Sahiwal lactating dairy cows, each identified with at least one specific subclinical mastitis quarter as per International Dairy Federation criteria. The cows were divided into two equal groups: a control group and a group administered O. sanctum leaf powder at 600 mg/kg body weight daily divided into two doses orally for 7 days. The treatment could eliminate 69.23% of intramammary infections (χ2 = 5.07; P ≤ 0.5) and resulted in a significant reduction in somatic cell count and ceruloplasmin concentration, thus subsiding udder inflammation and improving milk quality. The herb was also found to possess immunomodulation potential, as evidenced by the significant increase in phagocytic activity of milk neutrophils and enhanced lactoperoxidase and myeloperoxidase activities. Thus, the results indicated the immunotherapeutic potential of O. sanctum in treating bovine-specific subclinical mastitis.

___

  • 1. Hoeben D, Burvenich C, Heneman R. Influence of antimicrobial agents on bactericidal activity on bovine milk polymorphonuclear leukocytes. Vet Immunol Immunop 1997; 56: 271–282.
  • 2. Daley MJ, Hayes P. Mastitis: why is it so hard to cure? Cornell Vet 1992; 62: 1–9.
  • 3. Hovi M. 2001. Alternative therapy use on UK organic farms—Constraints and pitfalls. In: Proceedings of the 5th NAHWOA Workshop; 11–13 November 2001; Rodding, Denmark. Reading, UK: University of Reading.
  • 4. Prakash P, Gupta N. Therapeutic uses of Ocimum sanctumLinn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol 2005; 49: 125–131.
  • 5. Singh S, Malhotra M, Majumdar DK. Antibacterial activity of Ocimum sanctum L. fixed oil. Indian J Exp Biol 2005; 43: 835.
  • 6. Mukherjee R, Dash PK, Ram GC. Immunotherapeutic potential of Ocimum sanctum L. in bovine subclinical mastitis. Res Vet Sci 2005; 79: 37–43.
  • 7. Wynn SG, Fougere B. Veterinary Herbal Medicine. St. Louis, MO, USA: Mosby Elsevier; 2007.
  • 8. Shokeen P, Ray K, Bala M, Tandon V. Preliminary studies on activity of Ocimum sanctum, Drynaria quercifolia, and Annona squamosa against Neisseria gonorrhoeae. Sex Trans Dis 2008; 32: 106–111.
  • 9. National Mastitis Council. Microbiological Procedures for the Diagnosis of Bovine Udder Infections. Arlington, VA, USA: National Mastitis Council; 1990.
  • 10. Pandit AV, Mehta ML. Sodium lauryl sulphate as a substitute for CMT reagent (California Mastitis Test reagent) for diagnosis of sub clinical mastitis in buffaloes. Indian Vet J 1969; 46: 111–119.
  • 11. Dulin AM, Paape MJ, Nickerson SC. Comparison of phagocytosis and CL by blood and mammary gland neutrophil from multiparous and nulliparous cows. Am J Vet Res 1988; 49: 172–177.
  • 12. Daley MJ, Oldham ER, Williams TJ, Coyle PA. Quantitative and qualitative properties of host PMN cells during experimentally induced Staphylococcus aureus mastitis in cows. Am J Vet Res 1991; 52: 474–479.
  • 13. Colligan JE, Kruibeek AM, Marguhes DH, Shevach EM, Strober W. Current Protocols in Immunology. Vol. II. New York, NY, USA: Wiley; 1994.
  • 14. Gentle TA, Thompson RA. Neutrophil function tests in clinical immunology. In: Gooi HG, Chapel H, editors. Clinical Immunology. Oxford, UK: IRL Press; 1990. pp. 51–80.
  • 15. Boyne R, Arthur JR. Alteration of neutrophil function in selenium-deficient cattle. J Comp Pathol 1979; 89: 151–158.
  • 16. Bretz U, Baggiolini M. Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes. J Cell Biol 1974; 63: 251–269.
  • 17. Marshall VME, Cole WM, Bramley AJ. Influence of lactoperoxidase system on susceptibility of the udder to Streptococcus uberis infection. J Dairy Res 1986; 53: 507–514.
  • 18. Sunderman SW, Nomoto S. Measurement of human serum ceruloplasmin D by its p-phenylenediamine oxidase activity. Clin Chim Acta 1970; 16: 903–1010.
  • 19. Giacinti G, Rosati R, Boselli C, Tammaro A, Amatiste S, Ronchi B. Control of bovine sub-clinical mastitis by using herbal extract during lactation. In: 16th IFOAM Organic World Congress; 16–20 June 2008; Modena, Italy.
  • 20. Bansal BK, Gupta DK, Maini S, Ravikanth K, Randhawa SS. Evaluation of herbal therapy in specific subclinical mastitis of dairy cows - a clinical assessment. In: 15th International Conference of Production Diseases; 2013; Uppsala, Sweden. p. 198.
  • 21. Baskaran SA, Kazmer GW, Hinckley L, Andrew SM, Venkitanarayanan K. Antibacterial effect of plant-derived antimicrobials on major bacterial mastitis pathogens in vitro. J Dairy Sci 2009; 92: 1423–1429.
  • 22. Nielsen BH, Jacobsen S, Andersen PH, Niewold TA, Heegaad PMH. Acute phase protein concentration in serum and milk from healthy cows, cows with clinical mastitis and cows with extramammary inflammatory conditions. Vet Rec 2004; 154: 361–365.
  • 23. Gupta DK. Evaluation of immuno-therapeutic and antioxidative effects of some herbs in bovine subclinical mastitis. PhD, G. B. Pant University of Agriculture and Technology, Pantnagar, Uttarakhand, India, 2010.
  • 24. Belen B, Vangroenweghe F, Dosogne H, Burvenich C. Decreased neutrophil bactericidal activity during phagocytosis of a slime-producing Staphylococcus aureus strain. Vet Res Paris 2000; 31: 603–609.
  • 25. Rastogi S, Shukla Y, Paul BN, Chowdhuri DK, Khanna SK, Das M. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice. Toxicol Appl Pharmacol 2007; 224: 228–240.
  • 26. Andrei S, Pintea A, Groza I, Bogdan L, Cipue S, Matei S. Milk antioxidant enzymes activity in cows with subclinical mastitis. Lucrari Stiintifice Medicina University de Stiinte Agricole si Medicina Veterinara “Ion Ionescu de la Brad” Iasi 2009; 52: 1–6.